Oestrophan inj. ad us. vet.
|
0.25 mg/ml
|
V/NRP/96/0389
|
Bioveta, a.s., Čehija
|
QG02AD90
|
sows; mares; cows
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
solution for injection
|
International name (active substance): |
Cloprostenol
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
Date of authorisation/renewal: |
27-May-2011
|
Marketing authorisation valid until: |
Unlimited time period
|
Marketing authorisation procedure: |
NRP
|
Package leaflet: |
[DOCX] 27122023_LI (27-Dec-2023)
|
Labelling text: |
[DOCX] 27122023_M (27-Dec-2023)
|
Summary of product characteristics: |
[DOCX] 27122023_ZA (27-Dec-2023)
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/96/0389-01 |
0,25 mg |
10 |
Stikla ampula, 2 ml |
-
|
V/NRP/96/0389-02 |
0,25 mg |
1 |
Stikla flakons, 10 ml |
-
|
V/NRP/96/0389-03 |
0,25 mg |
1 |
Stikla flakons, 50 ml |
-
|
|
Oestrophan
|
0.25 mg/ml
|
V/I/19/0077
|
Bioveta, a.s., Čehija
|
QG02AD90
|
sows; mares; cows
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
solution for injection
|
International name (active substance): |
Cloprostenol
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
Date of authorisation/renewal: |
16-Dec-2024
|
Marketing authorisation valid until: |
15-Dec-2029
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] 16122024_LI (16-Dec-2024)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/19/0077-01 |
0,25 mg |
10 |
Stikla ampula, 2 ml |
[PDF]
[PDF]
|
V/I/19/0077-02 |
0,25 mg |
1 |
Stikla flakons, 10 ml |
[PDF]
[PDF]
|
|